EDAP TMS: Pioneer in Non-Invasive Urological Therapies

Since 1979, EDAP TMS has been innovating in the treatment of urological conditions through proprietary technologies like focused ultrasound and piezo-electric shock waves. The company develops minimally invasive devices for managing benign prostatic hyperplasia, localized prostate cancer, and urinary stones, prioritizing approaches that reduce side effects and recovery times.

Committed to research and development, EDAP TMS allocates 10% of its revenue to R&D and collaborates with institutional partners to drive innovation.